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Aims: Reports regarding the effects of antioxidants in obesity have been contradictory. Antioxidant 
N-acetylcysteine is usually considered a nutritional supplement. Our aim is to evaluate bioactivity of 
N-acetylcysteine (NAC) on mature adipocytes, which is a close model to in vivo condition. 
Study Design: In vitro study.  
Place and Duration of Study: Department of Basic Science (Universidad Nacional de Lujan), 
Department of Chemical Biology (Universidad de Buenos Aires), CONICET – INEDES and 
CONICET – IQUIBICEN, between March 2017 and June 2019. 
Methodology: We evaluated the bioactivity of different concentrations of NAC for 5 days (0.01 mM 
to 5 mM) on fully differentiated 3T3-L1 cells (mature adipocytes). 
Results: We demonstrated that NAC treatment was not toxic to mature adipocytes. Only 5mM NAC 
inhibited reactive oxygen species production. 5 mM NAC treatment resulted in a 60% decrease in 
cellular triglycerides content and inhibited 70% cholesterol accumulation.  We also determined the 
mRNA and protein expression levels of Peroxisome Proliferator-Activated Receptor  as well as, 
mRNA levels of lipid protein Perilipin in NAC treated adipocytes; we observed that 5mM NAC 
treatment caused nearly 30% decrease in the expression of these parameters.  
Conclusion: These results suggest that NAC could avoid lipid accumulation in mature adipocytes; 
the antioxidant NAC could be beneficial in obesity treatment. 
 
 




Obesity is a disorder involving an excessive 
accumulation of adipose tissue [1]. An increase 
in the number and size of adipocytes contributes 
to the etiology of obesity, characterized by 
excessive accumulation of lipids in white adipose 
tissue. White adipose tissue is widely distributed 
in the body, mainly as dermal, subcutaneous and 
mesenteric fat tissue. Oxidative stress occurs in 
this tissue, associated with insulin resistance, 
lead to systemic alterations such as metabolic 
syndrome [2]. Mature adipocytes account for 
about sixty percent of adipose tissue; also, blood 
cells, endothelial cells and adipocyte precursors 
with different degrees of cell differentiation are 
present in this tissue.  
 
3T3-L1 preadipocyte cell line has been isolated 
from cells derived from Swiss 3T3-8 mice 
embryos [3]. This cell line could differentiate into 
mature adipocytes and it is a useful model to test 
biological effect of antioxidant N-acetylcysteine 
(NAC) during adipogenesis [4-7]. 3T3-L1 
adipocyte differentiation occurs in response to 
insulin and dexamethasone, 70% - 90% of cells 
increase lipid droplets and their cellular 
triglyceride content after seven days of beginning 
cellular differentiation process [4]. Once the cells 
went through commitment checkpoint, they reach 
the complete restriction and differentiate in a 
terminal way [8]. Terminal adipocyte 
differentiated state (mature adipocytes) is 
maintaining by expression of some master 
regulators as adipocyte transcription factors such 
as Peroxisome Proliferator-Activated Receptor γ 
(PPARγ) that coordinate expression of the 
responsible genes for developing and 
maintenance of adipocyte phenotype [9].  We 
distinguish mature adipocytes based on their 
ability to accumulate triglycerides and express fat 
specific proteins such as ap2 and a protein 
surrounding lipid vacuoles named perilipin. 
Activation of PPARγ is crucial for adipocyte 
differentiation [5], because this transcription 
factor recognize a specific site in the promoter of 
terminal differentiation protein ap2 gene to 
induce its expression in adipocytes [6]; PPARγ is 
also responsible for perilipin expression in 
mature adipocytes [10].  
 
Treatment of 3T3-L1 with insulin, during 
differentiation protocol, rapidly generates a burst 
of hydrogen peroxide, which could have a strong 
impact on insulin signal transduction [11], thus 
reactive oxygen species (ROS) could be a 
component of intracellular redox signaling 
cascades [12,13]. In fact, ROS could facilitate 
preadipocyte differentiation [14]. It has been 
shown that adipogenesis is sensitive to 
extracellular redox environment [15]. We have 
previously showed that a pro-oxidant state 
occurred during preadipocyte to adipocyte 
differentiation pathway; addition of 0.01 mM        
NAC to cells increased the total intracellular  
GSH content by 25% after 1 day of treat-       












We have previously evaluated bioactivity of 
different non-toxic doses of antioxidant NAC on 
adipogenic differentiation pathways of 3T3-L1 
preadipocytes [5-7] and mouse embryonic 
fibroblasts [16]. We observed that NAC inhibited 
phosphorylation of mitogen-activated protein 
kinases in cell cultures [7,16] on the first day of 
differentiation protocol; this finding was 
consistent with another study using a known 
antioxidant such as epigallocatechin gallate [17]. 
We also demonstrated that NAC induced a 
decrease in PPARγ protein expression on the 
fourth day of differentiation process [5], similar to 
other groups, which confirmed that NAC blocks 
lipid accumulation by reducing cellular PPARγ 
protein expression during adipocyte 
differentiation [18-20]. However, the effects of 
NAC related with PPARγ in mature adipocytes 
have not yet been studied, which it is essential 
because adipose tissue is mainly composed of 
mature adipocytes and in a low percentage by 
differentiating precursor cells. Therefore, new 
experiments are necessary to evaluate NAC 
effect on cells when differentiation took place. 
We have previously evaluated antioxidants 
effectivity for treating several pathologies [21- 
24]. Here, our aim is to evaluate the effect of 
NAC on 3T3-L1 mature adipocytes, which 
represent a better model for obesity than those 
previously used.   
 
2. MATERIALS AND METHODS  
 
2.1 Cell Cultures and Drugs 
 
The 3T3-L1 cell line was obtained from the 
American Type Culture Collection (Rockville, 
MD, USA). The cells were cultured at 37°C with 
5% CO2 in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 25 mM glucose and 
10% fetal bovine serum. N-Acetylcysteine was 
purchased from Sigma- Aldrich Inc., USA.  
 
2.2 3T3-L1 Adipocyte Differentiation 
 
The 3T3-L1 preadipocytes were first cultured in 
MDI medium (0.5 mM 3-isobutyl-1-methyl 
xanthine, 0.1 μM dexamethasone, and 2 μM 
insulin) for 48 hours. Then they were transferred 
to fresh DMEM (with 25 mM glucose and 10% 
FBS) supplemented with 2 μM insulin and 
incubated for three days. After three days, cells 
were then cultured in fresh DMEM (with 25 mM 
glucose and 10% FBS) for the remainder of the 
experiment. Day 0 of differentiation protocol was 
defined as the time at which the cells were first 
cultured in MDI medium. At day 7, the cellular 
triglyceride (Tg) content dramatically increased 
by 70 – 80%, thereby generating refractive 
droplets that were clearly observed by 
microscopy. These cells (at day 7) were 
considered as mature adipocytes (AC). On day 7 
of differentiation protocol, various concentrations 
of NAC were added to the cells and maintained 
throughout the remainder of the experiment; 
these cells were considered as NAC-treated 
mature adipocytes (ACN). DMEM (with 25 mM 
glucose and 10% FBS) was used as the vehicle 
and vehicle-treated cells were considered as 
control cells (CC) as previously described [5]. 
 
2.3 Measurement of Intracellular Free –
SH (thiol: -SH) 
 
To evaluate cellular free thiols, we performed 
assays on mature adipocytes (AC) using different 
concentrations of NAC including 0.01 mM, 0.1 
mM NAC, 1 mM, 5 mM and 10 mM. On day 7 of 
differentiation protocol, NAC was added to the 
cells, and the treatment continued for 5 days. At 
day 12 of differentiation protocol, the cells were 
washed with PBS at RT and then 0.2 - 1 mL of 
water was added. The cells were then scraped 
and evaluated for cellular free thiols and proteins 
for each treatment. Free thiols content were 
assessed using Raggi method [25]. Briefly, the 
technique is based on an oxide-reduction 
reaction. The oxidation of thiols (present in the 
molecules to be evaluated) in the presence of Fe 
(III) and phenathroline, gives a stable compound 
1,10 phenanthroline - Fe (II) which could be 
determined at 515nm. Proteins were quantified 
by the Bradford method using crystalline bovine 
serum albumin as the standard. Results of 
experiments were normalized by protein content. 
The absorbance of mature adipocytes without 
NAC treatment (0) was evaluated at day 12 and 
set to 1, the results are presented as fold 
increase of them [5]. 
 
2.4 MTT Assay  
 
To evaluate the toxicity of NAC treatment, on 
mature adipocytes (AC), MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) viability assay was performed [26]. The 
technique is based on the presence of 
mitochondrial enzymes in viable cells that reduce 
the MTT dye and produce a purple color. We 
followed the previous published protocol [16]. To 
evaluate toxicity, cell viability assays were 
performed using different concentrations of NAC 
including 0.01 mM, 0.1 mM, 1 mM and 5 mM. On 











to the cells, and the treatment continued for 5 
days. Cellular viability was evaluated at day 12 of 
differentiation protocol for each treatment. The 
absorbance of mature adipocytes without NAC 
treatment (0) was evaluated at day 12 and set to 
1, the results are presented as fold increase of 
them [16]. 
 
2.5 Measurement of Intracellular ROS 
Generation 
 
To evaluate ROS in mature adipocytes, the cells 
were washed with 0.01 M phosphate buffered 
saline at room temperature and, then incubated 
in the dark for 1 hour at 37°C with a cell-
permeable probe CM-H2DCFDA that becomes 
fluorescent under oxidation and emits green 
fluorescence. Fluorescence emission was 
detected at 520 nm, with an excitation 
wavelength at 505 nm. ROS production was 
determined from a standard curve using H2O2 
(0.1–5 μM), the fluorescence intensities of H2O2 
solutions were plotted vs H2O2 nmoles. Results 
of experiments were normalized by protein 
content [5]. Mature adipocytes without NAC 
treatment (AC) and NAC treated adipocytes 
(ACN - 0.01: 0.01 mM NAC; ACN - 0.1: 0.1 mM 
NAC; ACN - 1: 1 mM NAC; ACN - 5: 5 mM NAC) 
were evaluated, as well as, non-differentiated 
3T3-L1 control cells (CC). Briefly, on day 7 of 
differentiation protocol, NAC was added to 
mature adipocytes, and the treatment continued 
for 5 days. Fluorescence was evaluated at day 
12 of differentiation protocol for each treatment. 
The absorbance of control cells without NAC 
treatment (CC) was evaluated at day 12 and set 
to 1, the results are presented as fold increase of 
them [5]. 
 
2.6 Measurement of Triglyceride, 
Cholesterol and Protein Levels 
 
Adipocytes (AC) and 5 mM NAC treated 
adipocytes (ACN - 5) were evaluated, as well as, 
non-differentiated 3T3-L1 control cells (CC). 
Briefly, on day 7 of differentiation protocol, NAC 
was added to mature adipocytes, and the 
treatment continued for 5 days. Cell were 
washed with PBS at RT and then 0.2 - 1 mL of 
water was added. The cells were then scraped 
and evaluated for triglycerides, cholesterol and 
proteins. Triglyceride and cholesterol 
accumulation were assessed using the TG color 
GPO/PAP AA kit (Wiener Laboratory, Rosario, 
Argentina) and Colestat AA kit (Wiener 
Laboratory, Rosario, Argentina), respectively. 
Proteins were quantified by the Bradford method 
using crystalline bovine serum albumin as the 
standard. Results of experiments were 
normalized by protein content. The absorbance 
of control cells without NAC treatment (CC) was 
set to 100, the results are presented as 
percentage of them [4]. 
 
2.7 Western Blotting 
 
Adipocytes (AC), NAC treated adipocytes (ACN - 
0.01: 0.01 mM NAC; ACN - 0.1: 0.1 mM NAC; 
ACN - 1: 1 mM NAC; ACN - 5: 5 mM NAC) and 
non-differentiated 3T3-L1 control cells (CC) 
samples were obtained on day 12 of the 
differentiation protocol. NAC was added on day 7 
of differentiation protocol to mature adipocytes, 
and the treatment continued for 5 days. We 
followed the previous published protocol [16]. 
The primary antibodies included anti-PPARγ and 
GAPDH (PPARγ (E-8) and GAPDH, Santa Cruz 
Biotechnology, USA). The membranes were then 
probed with horseradish-peroxidase-conjugated 
secondary antibodies (Santa Cruz 
Biotechnology, USA) and protein signal was 
detected using the enhanced 
chemiluminescence (ECL) substrate kit 
(Amersham ECL Plus Western Blotting Detection 
System, GE Healthcare, USA). PPARγ 
expression was normalized to GAPDH 
expression. Control cells (CC) without NAC 
treatment was evaluated at day 12 and set to 1, 
the results are presented as fold increase of 
them. The results are expressed as arbitrary 
units.  
 
2.8 RNA Extraction and RT-qPCR 
Analysis 
 
Adipocytes (AC) and 5 mM NAC treated 
adipocytes (ACN – 5) were obtained on day 9 of 
differentiation protocol. Briefly, on day 7 of 
differentiation protocol, NAC was added to 
mature adipocytes, and the treatment continued 
for 2 days. Total RNA extraction from 3T3-L1 
cells was performed using the TRI Reagent 
(Molecular Research Center, USA). The relative 
mRNA expression was determined by 
quantitative real-time PCR using a Bio-Rad 
MyIQ2 thermal cycler. Each PCR reaction was 
performed using 5 pmol of each primer. The 
following cycling conditions were used: 94°C for 
5 minutes, followed by 40 cycles of 94°C for 20 
seconds, 58°C for 30 seconds and 72°C for 40 
seconds. Target gene mRNA expression was 
normalized to acidic ribosomal protein (Rplp0) as 
a reference gene. Perilipin 1 (Plin1) primers were 
designed using Primer-3 (v.-0.4.0) software. 











obtained from published reports. Mature 
adipocytes without treatment (AC) was evaluated 
at day 9 and set to 1, the results are presented 
as fold increase of them. The results are 
expressed as arbitrary units [27].  
 












Results are expressed as the mean ± standard 
deviation (SD). Statistical analysis was 
performed by one-way analysis of variance 
followed by post hoc analysis [28]. The results 
represent the average of four independent 
experiments (mean ± SD), *P = .001 vs mature 
adipocytes without NAC treatment was 
considered statistically significant.  
3. RESULTS  
 
We induced differentiation of 3T3-L1 
preadipocytes and at day 7, we observed fully 
differentiated cells; they showed refractive lipid 
droplets as detected by microscopy and 
increased their triglyceride content compared to 
3T3-L1 non-differentiated preadipocytes (non-
differentiated control cells). Therefore, we 
considered these fully differentiated cells as 
mature adipocytes (AC). On day 7, triglyceride 
(Tg) content in AC was almost four times higher 
than Tg content observed in non-differentiated 
control cells (CC) (0.83 ± 0.15 g Tg/g protein 
[AC] vs. 0.23 ± 0.1 g Tg/g protein [CC],                
P = .000).  
 
We added NAC to the media on day 7 of 
differentiation protocol and evaluated its effect on 
3T3-L1 mature adipocytes after 5 days. We used 
doses from 0.01 to 10 mM to determine cellular 
uptake of NAC, we observed that only the 
highest doses, such as 5 mM and 10 mM, 
significantly increased free total thiols in a 
saturable way in NAC treated mature adipocytes 




Fig. 1. Effect of NAC on intracellular free-SH in 3T3-L1 mature adipocytes: 3T3-L1 mature 
adipocytes were treated on day 7 of differentiation protocol with 0.01mM NAC (0.01), 0.1 mM 
NAC (0.1), 1 mM NAC (1), 5 mM NAC (5) or 10mM NAC (10). 3T3-L1 mature adipocytes without 
NAC treatment were also evaluated (0).  Cells were harvested on day 12 and intracellular free 
thiols level was determined. The absorbance of mature adipocytes without NAC treatment (0) 
was evaluated and set to 1, theresults are presented as fold increase of them. The results are 
the average of four different experiments (mean + SD). * This indicates P = .001 : statistically 


































Fig. 2. Effect of NAC on cell viability in 3T3-L1 mature adipocytes: 3T3-L1 adipocytes were 
treated on day 7 of differentiation protocol with 0.01 mM NAC (0.01), 0.1 mM NAC (0.1), 1 mM 
NAC (1) or 5 mM NAC (5). 3T3-L1 mature adipocytes without NAC treatment were also 
evaluated (0). Cells were harvested on day 12 and MTT assay was performed. The absorbance 
of mature adipocytes without treatment (0) was evaluated and set to 1, the results are 
represented as a fold increase of them. The results are the average of four different 




Fig. 3. Effect of NAC on ROS level in 3T3-L1 mature adipocytes: 3T3-L1 mature adipocytes 
were treated on day 7 of differentiation protocol with 0.01 mM NAC (ACN-0.01), 0.1 cmM NAC 
(ACN-0.1), 1 mM NAC (ACN-1) or 5 mM NAC (ACN-5). 3T3-L1 mature adipocytes without NAC 
treatment (AC) and 3T3-L1 non-differentiated control cells without NAC treatment (CC) were 
also evaluated. Cells were harvested on day 12 and intracellular ROS level was determined. 
The absorbance of control cells (CC) was evaluated and set to 1, the results are presented as 
fold increase of CC. The results are the average of four different experiments (mean + SD). * 
This indicates P = .000 : statistically significant when compared to mature adipocytes without 



















































We found that 0.01 – 5 mM NAC doses were not 
toxic to  mature adipocytes as shown in Fig. 2; 
we set non-treated mature adipocytes viability to 
1 (1+0.12 [0 mM NAC] vs 1.05+0.02 [5 mM 
NAC], P = 0.85, no significant difference was 
observed).  
 
We observed an increase in reactive oxygen 
species (ROS) level two-fold higher in mature 
adipocytes than in non-differentiated control cells 
and, assayed different doses of NAC on mature 
adipocytes for 5 days. We demonstrated that 
only 5 mM NAC could significant decrease 
intracellular ROS level in NAC treated mature 
adipocytes almost 30% (Fig. 3). 
 
After 5-days treatment with 5 mM NAC in mature 
adipocytes, at day 12, we observed a significant 
decrease in cellular Tg content in NAC treated 
adipocytes compared to non-treated adipocytes 
(Fig. 4). Is relevant to point out that a 60% 
decrease in triglyceride accumulation was 
observed with the treatment (1.22+0.09 g Tg/g 
protein [AC] vs 0.49+0.03 g Tg/g protein [ACN-
5], P = .000). Whereas, on day 12, non-
differentiated control cells (CC) had four times 
lower Tg content than AC (1.22 ± 0.09 g Tg/g 
protein [AC] vs. 0.3 ± 0.05 g Tg/g protein [CC], P 
= .000). 5 mM NAC treatment also decreased 
nearly 70% cellular cholesterol accumulation in 
ACN-5 at day 12 compared to AC (Fig. 4). 
 
After 5 days NAC treatment, on day 12 of 
differentiation protocol, we evaluated PPARγ 
protein expression. As shown in Fig. 5, only 5 
mM NAC treatment induced a 30% decrease in 
PPARγ protein level (PPARγ/GAPDH: 1.54+0.12 
[AC] vs 1.08+0.08 [ACN-5] AU; P = .005). After 
addition of 5 mM NAC to the media for 2 days 
(on day 9 of differentiation protocol), we 
evaluated mRNA levels of PPARγ by RT-qPCR 
(Fig. 6), and observed a similar decrease in both 
PPARγ protein and mRNA levels (PPARγ/ Rplp0: 




Fig. 4. Effect of NAC on lipid accumulation in 3T3-L1 mature adipocytes: 3T3-L1 mature 
adipocytes were treated on day 7 of differentiation protocol with 5mM NAC (ACN-5). 3T3-L1 
mature adipocytes without NAC treatment (AC) and 3T3-L1 non-differentiated control cells 
without NAC treatment (CC) were also evaluated. Cells were harvested on day 12 and 
intracellular triglyceride or cholesterol content was determined. The absorbance of control 
cells (CC) was evaluated and set to 100, the results are presented as percentage of CC. The 
results are the average of four different experiments (mean + SD). * This indicates P = .000 : 
statistically significant when compared to mature adipocytes without NAC treatment (AC). 
Triglyceride content: *P = .000 [ACN-5 vs AC]; *P = .000 [CC vs AC]. Cholesterol content: *P = 














Fig. 5. Effect of NAC on PPARγ (PPAR g) in 3T3-L1 mature adipocytes: 3T3-L1 mature 
adipocytes were treated on day 7 of differentiation protocol with 0.01mM NAC (ACN-0.01), 
0.1mM NAC (ACN-0.1), 1mM NAC (ACN-1) or 5mM NAC (ACN-5). 3T3-L1 mature adipocytes 
without NAC treatment (AC) and 3T3-L1 non-differentiated control cells without NAC treatment 
(CC) were also evaluated. Cells were harvested on day 12 and western blot assay was 
performed. PPARγ protein expression was normalized to GAPDH expression. The values 
represent fold increase in the expression of adipogenic transcription factor versus the 
expression of control cells (CC) harvested on day 12. Representative results from one of three 
independent western blot experiments with similar results are shown. The results are 
represented as arbitrary units and they are the average of three different experiments (mean + 
SD). *P = .005 vs mature adipocytes without NAC treatment (AC). PPARγ (PPARg): 
peroxisomal proliferator activated receptor gamma; GAPDH: Glyceraldehyde 3-phosphate 
dehydrogenase 
 
We also quantified mRNA levels of perilipin, after 
treating mature adipocytes with 5 mM NAC for 2 
days (Fig. 6). We could not detect mRNA 
perilipin in non-differentiated 3T3-L1 control cells; 
therefore, we set AC content mRNAs to 1. A 
significant decrease was observed in ACN-5 
compared to AC (1+0.09 AU [AC] vs 0.72+0.07 




3T3-L1 preadipocyte cell line has been                     
widely used for the study of adipogenic 
differentiation process [9,29]. As a result, it is 
possible to observe in mature adipocytes the 
phenotypical changes occurring during 
adipogenesis; at day 7 of differentiation protocol 
lipid droplets are visible at optical microscope 
and a drastic cellular morphology of the cells is 
also observed [6, 7]. 
There is a close relationship between obesity 
and oxidative stress [30], with increasing 
evidence suggesting a role for oxidative stress 
and free radicals in promoting adipogenesis [14, 
31]. A pro-oxidant state occurs during adipogenic 
differentiation in 3T3-L1 cell line, in the absence 
of an appropriate compensatory response from 
the endogenous antioxidant network, the system 
could become overwhelmed. Therefore, to avoid 
accumulation of ROS and their potentially 
deleterious effects, several cellular enzymes 
such as SOD and GPx detoxify them [5]. Most of 
the studies evaluate antioxidants effects on this 
cell line during 3T3-L1 cellular adipocyte 
differentiation and, external agents are adding 
together with inducing adipogenic agents to the 
cells. Nevertheless, mature adipocytes could not 
response to external agents. Since more than 











mature adipocytes, new studies could be 
necessary to evaluate external antioxidants 
effects on them. 
 
Several reports, summarized in a recent review, 
demonstrated that NAC could inhibit ROS 
production as well as lipid accumulation during 
differentiation of 3T3-L1 preadipocytes [32]; in 
fact, we had confirmed that 0.01mM NAC 
assayed on preadipocytes, was effective in 
decreasing ROS and lipid accumulation during 
cellular adipocyte differentiation [5]. Here, we 
used NAC on terminal adipocyte differentiated 
cells to study a possible lipid accumulation. We 
added NAC to the culture medium at day 7 of 
differentiation protocol; at pH medium (nearly 7 - 
8), NAC should be negatively charged [33]. 
Therefore, NAC could enter in mature adipocytes 
via anion exchange protein transport [34]. We 
conducted experiments to determine NAC 
adipocytes uptake, by testing cellular free-thiol 
content, because the presence of thiol group in 
NAC. We observed that dose of 5 mM NAC 
allowed the greatest uptake compared to lower 
doses. It is important to point out, that cells 
contain different kind of molecules with thiol 
groups, such as glutathione, which it is high in 
mature adipocytes [5]; an increase in free-thiols 
level in NAC treated mature adipocytes above 
basal content could suggest that cells 
incorporated NAC. We showed saturable NAC 
incorporation, 10 mM dose did not induce a 
higher free-thiols cellular uptake than 5 mM 
dose.  
 
Dose from 0.01 mM to 5 mM NAC were not toxic 
to cells during the treatments. We observed an 
increase on ROS level in mature adipocytes, but 
only 5 mM NAC was effective in decreasing 
cellular oxidant species, according to NAC 
uptake. Other authors used similar doses of NAC 
in mature adipocytes to inhibit ROS production 
[35,36]. Therefore, we decided to evaluate this 
dose on lipid accumulation in 3T3-L1 mature 
adipocytes. 
 
5 mM NAC treatment was significantly effective 
in inhibiting Tg and Cholesterol accumulation in 
3T3-L1 mature adipocytes. Triglyceride content 
significantly decreased from day 7 to day 12 in 
NAC treated mature adipocytes; we could 
suggest that NAC treatment was effective in 
avoiding triglyceride accumulation in these cells. 
Tg accumulation in adipocytes correlates with an 
increase in cellular ROS level [5,37], meanwhile 
NAC is a ROS scavenger and precursor to GSH, 
one of the main cellular antioxidant molecule. 




Fig. 6. Effect of NAC on mRNA PPARγ (PPAR g) or mRNA perilipin in 3T3-L1 mature 
adipocytes: 3T3-L1 mature adipocytes were treated on day 7 with 5mM NAC (ACN-5). 3T3-L1 
mature adipocytes without NAC treatment (AC) and 3T3-L1 non-differentiated control cells 
without NAC treatment (CC) were also evaluated. Cells were harvested on day 9 and qPCR 
assay was performed. Relative expression of mRNA PPARγ or mRNA perilipin were 
normalized to acidic ribosomal protein (Rplp0) as a reference gene. The values represent 
fold increase in mRNA level versus the level in mature adipocytes without NAC treatment 
(AC) harvested on day 9. None mRNA perilipin was detected in CC. The results are 
represented as arbitrary units and they are the average of three different experiments (mean 
+ SD). PPARg: *P = .026 [ACN-5 vs AC]; *P = .000 [CC vs AC]. Perilipin: *P = .013 [ACN-5 vs 






























adipogenesis, the antioxidant environment 
generated by NAC treatment had an inhibitory 
effect on lipid accumulation. We demonstrated 
that NAC, despite its low cellular uptake, could 
be effective as antioxidant. Our results suggest 
that reduction of oxidative state, due NAC 
addition, could cause inhibition in Tg and 
cholesterol accumulation in mature adipocytes. 
Other authors that have used NAC during 
adipocyte differentiation, reported similar results 
[18,20,38,39]. Therefore, we could speculate 
about a possible use of this molecule as a new 
drug or as an adjuvant to decrease lipid content 
in human adipose tissue during obesity 
development. 
 
Early studies have demonstrated that PPARγ 
expression increase during adipogenesis; it is 
necessary and sufficient for adipocytes 
differentiation, thereby establishing PPARγ as a 
master regulator of adipogenesis [40]. Some 
authors have shown that elevation of ROS is 
required in activation of PPARγ in mesenchymal 
stem cells, during adipocyte differentiation [19], 
while antioxidants are effective inhibiting 
adipogenesis in vitro [41]. We have also reported 
a correlation between ROS and PPARγ 
expression during differentiation of 3T3-L1 
preadipocytes, while NAC was effective in 
inhibiting PPARγ expression during cellular 
differentiation [5]. Therefore, we decided to 
evaluate the effect of this antioxidant on this 
adipogenic transcription factor in mature 
adipocytes. Here, we showed that PPARγ mRNA 
and protein levels were higher in mature 
adipocytes than in non-differentiated 
preadipocytes. We observed that 5 mM NAC 
treatment in mature adipocytes caused a 
reduction in both PPARγ mRNA level and protein 
expression. These results were in contradiction 
with those reported by Liu et al. [42]; but they 
evaluated NAC treatment on tamoxifen-
pretreated 3T3-L1 adipocytes, and informed that 
NAC increased PPARγ protein level in these 
cells. However, they showed that PPARγ protein 
expression was lower in NAC tamoxifen-
pretreated adipocytes than in mature adipocytes. 
Since PPARγ is a key factor in adipogenesis and 
its expression is enough to maintain mature 
adipocyte phenotype, we suggest that NAC could 
mediate its effect by inhibiting this transcription 
factor expression in these cells, and therefore 
lipid accumulation effectively decreased in 
mature adipocytes.  
 
The decrease of PPARγ, suggest that adipocytes 
could lose their storage capacity of lipids, the 
main function of mature adipocyte. In 
preadipocytes small lipid droplets are coated with 
an adipocyte differentiation related protein 
named ADRP, once cells differentiated into 
mature adipocytes, these cells produce much 
larger fat droplets, that could see at microscope,  
and perilipin protein displaces ADRP from 
droplets surface. Perilipin is a protein found 
exclusively on the outer surface of lipid vacuoles 
in mature adipocytes, which protects lipids from 
de action of lipases [43]. Therefore, we 
determined perilipin in NAC treated mature 
adipocytes, and showed that its mRNA level 
significantly decreased compared to none-
treated NAC adipocytes. This fall in perilipin 
could partly explained since its expression is 
upregulated by PPARγ [10]. We could speculate 
a possible lipolysis process, because perilipin 
could modulate lipolysis by controlling the access 
of lipases within lipid droplets [44]. 
 
We have previously showed an inhibitory effect 
of NAC on MAPKs signaling pathway during 
adipocyte differentiation in both 3T3-L1 
preadipocytes [7] and mouse embryonic 
fibroblasts [16]. We observed that a minimum 
dose of NAC, such as 0.01 mM, could inhibit 
mitotic clonal expansion [7] and, terminal lipid 
protein ap2 expression [6] during 3T3-L1 cellular 
differentiation. However, this is the first time to 
assay NAC on mature adipocytes, after complete 
3T3-L1 cellular differentiation, and we observed 
that higher dose of NAC was active in mature 
adipocytes than that previously used. NAC is 
usually included in food supplements; our results 
suggest that NAC could prevent lipid 
accumulation in mature adipocytes. It is unclear 
to what extent these new results from this in vitro 
study might extrapolate to in vivo condition, but it 
is clear that NAC could potentially have a 
regulatory effect on lipid accumulation in mature 
adipocytes.  Some authors reported that 
treatment of obese patients with 2 mM NAC 
administered daily decreased body fat mass, 
producing an increase of 25% of total plasma 
thiol in these patients [45]. Another report 
revealed that antioxidant rich diet is inversely 





This is the first report evaluating the effect of 
NAC on 3T3-L1 mature adipocytes. Our results 
demonstrated that a dose of 5 mM NAC prevents 
cellular cholesterol and triglyceride accumulation 











involving the inhibition of PPARγ expression in 
the cells. More studies are necessary to 
investigate the potential impact of NAC on 
obesity treatment; but this approach is closer to 
that could happen in adipose tissue during 
obesity, since mature adipocytes are the 
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